Gorlin-Goltz syndrome

Changed by Alexandra Stanislavsky, 17 Nov 2015

Updates to Article Attributes

Body was changed:

Gorlin-Goltz syndrome,also known as the basal cell naevus syndrome, is a rare phakomatosis characterized by multiple odontogenic keratocysts, multiple basal cell carcinomas, and other abnormalities.

Epidemiology

The condition is thought to occur in ~1 in 60,000 live births while 0.4% of patients with a basal cell carcinoma are estimated to have Gorlin syndrome. ~2% and 22% of patients with a basal cell carcinoma younger than 45 years and 19 years of age, respectively, are estimated to have the syndrome. 

Clinical presentation

Pathology

Genetics

It is an autosomal dominant syndrome with complete penetrance and variable expressivity. It is related to mutation in PTCH tumour suppressor gene on chromosome 9. 35-50% of affected individuals are the result of new mutations. Individuals with the syndrome are sensitive to ionizing radiation.

Diagnosis

A clinical diagnosis can be made using major and minor criteria. To make the diagnosis, either two major or one major and two minor criteria must be met.

Major criteria
  • basal cell carcinoma: >2 or 1 under the age 20
  • odontogenic keratocysts (see case 1)
  • palmar pits: 3 or more
  • bilamellar calcification of the falx cerebri
  • rib anomalies: bifid rib (see image), fused, splayed
  • first degree relative with Gorlin syndrome
Minor criteria

History and etymology

It was first described by R J Gorlin (1923-2006) and R W Goltz (1923-) in 1960 2.

  • -</ul><h4>Pathology</h4><h5>Genetics</h5><p>It is an autosomal dominant syndrome with complete penetrance and variable expressivity. It is related to mutation in PTCH tumour suppressor gene on chromosome 9. 35-50% of affected individuals are the result of new mutations. Individuals with the syndrome are sensitive to ionizing radiation.</p><h5>Diagnosis</h5><p><span style="font-size:13px; line-height:1.6">A clinical diagnosis can be made using major and minor criteria. To make the diagnosis, either two major or one major and two minor criteria must be met.</span></p><h5>Major criteria</h5><ul>
  • +</ul><h4>Pathology</h4><h5>Genetics</h5><p>It is an autosomal dominant syndrome with complete penetrance and variable expressivity. It is related to mutation in PTCH tumour suppressor gene on chromosome 9. 35-50% of affected individuals are the result of new mutations. Individuals with the syndrome are sensitive to ionizing radiation.</p><h5>Diagnosis</h5><p>A clinical diagnosis can be made using major and minor criteria. To make the diagnosis, either two major or one major and two minor criteria must be met.</p><h5>Major criteria</h5><ul>

ADVERTISEMENT: Supporters see fewer/no ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.